We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
The Association of the British Pharmaceutical Industry has suspended Astellas UK from the trade group, citing “serious breaches” of the group’s Code of Practice for the Pharmaceutical Industry. Read More
The FDA made strides in its quality metrics endeavors Friday, complementing a draft guidance for submitting quality metrics data with a host of technical recommendations. Read More
Industry is asking the FDA to clarify key elements of its updated draft guidance on assessing the effects of protein-based treatments on the immune system. Read More
Brexit is unlikely to spur monumental changes for the life science industry, but regulatory compliance experts do acknowledge the possibility of many headaches. Read More